[{"AccountsPayableCurrent_0_Q3_USD":13502000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":107000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-170000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-32000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-9000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":154000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":139000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":154000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":139000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":186000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":148000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":374000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":2527000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":34276000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":27172000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2662000.0,"OperatingIncomeLoss_3_Q3_USD":-211676000.0,"OperatingIncomeLoss_1_Q3_USD":-79668000.0,"NonoperatingIncomeExpense_3_Q3_USD":107000.0,"NonoperatingIncomeExpense_1_Q3_USD":-170000.0,"NetIncomeLoss_3_Q3_USD":-211569000.0,"NetIncomeLoss_1_Q3_USD":-79838000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-173648000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":77896000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":12912000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":49926000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":40000.0,"PaymentsToAcquireInProcessResearchAndDevelopment_3_Q3_USD":4000000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":313718000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3079000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":57948612.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":58107611.0,"ValuationAllowancesAndReservesBalance_0_Q3_USD":7116000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":4364000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1706000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":8548000.0,"StockholdersEquity_0_Q3_USD":380457000.0,"SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0_Q3_USD":12600000.0,"ShareBasedCompensation_3_Q3_USD":35284000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":99102000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":35527000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":462000.0,"MarketableSecurities_0_Q3_USD":289081000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":71949000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-966037000.0,"RestrictedInvestmentsNoncurrent_0_Q3_USD":3102000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":182109000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":66444000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_3_Q3_USD":4000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":10820000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":0.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":38617000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":360076000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":4364000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":8588000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":17722000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":23220000.0,"LiabilitiesCurrent_0_Q3_USD":75789000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":483418000.0,"Liabilities_0_Q3_USD":102961000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-79699000.0,"CommonStockValue_0_Q3_USD":583000.0,"CommonStockSharesOutstanding_0_Q3_shares":58327889.0,"CommonStockSharesIssued_0_Q3_shares":58327889.0,"CommonStockSharesAuthorized_0_Q3_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-82840000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":53189000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":53189000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_3_Q3_USD":61000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_3_Q3_USD":40000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-211415000.0,"AssetsFairValueDisclosure_0_Q3_USD":372206000.0,"Assets_0_Q3_USD":483418000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7279132.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":35284000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":11794000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":35284000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":11794000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1345746000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":165000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":6121000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":59625000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1392000.0,"AccountsReceivableNetCurrent_0_Q3_USD":18049000.0,"AssetsCurrent_0_Q3_USD":385294000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":58107611.0,"CostOfGoodsAndServicesSold_1_Q3_USD":917000.0,"CostsAndExpenses_1_Q3_USD":102888000.0,"InvestmentsAndCash_0_Q3_USD":392200000.0,"InventoryWriteDown_3_Q3_USD":100000.0,"InventoryWriteDown_1_Q3_USD":0.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":4443000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1352000.0,"InventoryNet_0_Q3_USD":7253000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":1458000.0,"IncreaseDecreaseOfRestrictedInvestments_3_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5240000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":-1849000.0,"IncreaseDecreaseInInventories_3_Q3_USD":3275000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":5823000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":2414000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":4153000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":106800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":16091000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":132000.0,"EarningsPerShareDiluted_3_Q3_USD":-3.65,"EarningsPerShareDiluted_1_Q3_USD":-1.37,"EarningsPerShareBasic_3_Q3_USD":-3.65,"EarningsPerShareBasic_1_Q3_USD":-1.37,"DepreciationDepletionAndAmortization_3_Q3_USD":2234000.0,"DebtSecuritiesAvailableForSaleExcludingAccruedInterest_0_Q3_USD":339007000.0,"DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_0_Q3_USD":339028000.0,"CostsAndExpenses_3_Q3_USD":283625000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1178000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":57948612.0,"Ticker":"DCPH","CIK":"1654151","name":"DECIPHERA PHARMACEUTICALS, INC.","OfficialName":"Deciphera Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"586694767.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211102"}]